• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

llamanade:一个用于稳健纳米抗体人源化的开源计算流程。

Llamanade: An open-source computational pipeline for robust nanobody humanization.

机构信息

Department of Cell Biology, Pittsburgh, PA, USA; Department Computational and Systems Biology, Pittsburgh, PA, USA; University of Pittsburgh-Carnegie Mellon University Program in Computational Biology, Pittsburgh, PA, USA.

Department of Cell Biology, Pittsburgh, PA, USA.

出版信息

Structure. 2022 Mar 3;30(3):418-429.e3. doi: 10.1016/j.str.2021.11.006. Epub 2021 Dec 10.

DOI:10.1016/j.str.2021.11.006
PMID:34895471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698024/
Abstract

Nanobodies (Nbs) have emerged as a promising class of biologics. Despite having marked physicochemical properties, Nbs are derived from camelids and may require humanization to improve translational potentials. By systematically analyzing the sequence and structural properties of Nbs, we found substantial framework diversities and revealed the key differences between Nbs and human immunoglobulin G antibodies. We identified conserved residues that may contribute to enhanced solubility, structural stability, and antigen binding, providing insights into Nb humanization. Based on big data analysis, we developed "Llamanade," an open-source software to facilitate rational humanization of Nbs. Using sequence as input, Llamanade can rapidly extract sequence features, model structures, and optimize solutions to humanize Nbs. Finally, we used Llamanade to successfully humanize a cohort of structurally diverse and potent SARS-CoV-2 neutralizing Nbs. Llamanade is freely available and will be easily accessible on a server to support the development of therapeutic Nbs into safe and effective trials.

摘要

纳米抗体(Nbs)已经成为一类有前途的生物制剂。尽管具有显著的物理化学特性,但 Nbs 来源于骆驼科动物,可能需要进行人源化改造以提高转化潜能。通过系统分析 Nbs 的序列和结构特性,我们发现了大量的框架多样性,并揭示了 Nbs 与人类免疫球蛋白 G 抗体之间的关键差异。我们鉴定了可能有助于提高溶解度、结构稳定性和抗原结合的保守残基,为 Nb 人源化提供了见解。基于大数据分析,我们开发了“Llamanade”,这是一款开源软件,可促进 Nbs 的合理化人源化。使用序列作为输入,Llamanade 可以快速提取序列特征、建模结构,并优化 Nbs 人源化的解决方案。最后,我们使用 Llamanade 成功地对一组结构多样且有效的 SARS-CoV-2 中和 Nbs 进行了人源化改造。Llamanade 是免费提供的,并将在服务器上轻松访问,以支持将治疗性 Nbs 开发为安全有效的试验。

相似文献

1
Llamanade: An open-source computational pipeline for robust nanobody humanization. llamanade:一个用于稳健纳米抗体人源化的开源计算流程。
Structure. 2022 Mar 3;30(3):418-429.e3. doi: 10.1016/j.str.2021.11.006. Epub 2021 Dec 10.
2
: an open-source computational pipeline for robust nanobody humanization.用于可靠的纳米抗体人源化的开源计算流程
bioRxiv. 2021 Aug 4:2021.08.03.455003. doi: 10.1101/2021.08.03.455003.
3
Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.针对 SARS-CoV-2 受体结合域的纳米抗体的计算设计与建模。
Chem Biol Drug Des. 2021 Jul;98(1):1-18. doi: 10.1111/cbdd.13847. Epub 2021 May 13.
4
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.一种新型针对中东呼吸综合征冠状病毒(MERS-CoV)受体结合域的纳米抗体具有强大的交叉中和活性和针对 MERS-CoV 的保护效力。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.00837-18. Print 2018 Sep 15.
5
Identification of a potent SARS-CoV-2 neutralizing nanobody targeting the receptor-binding domain of the spike protein.鉴定一种针对刺突蛋白受体结合域的强效 SARS-CoV-2 中和纳米抗体。
Int J Biol Macromol. 2024 Nov;281(Pt 2):136403. doi: 10.1016/j.ijbiomac.2024.136403. Epub 2024 Oct 9.
6
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies.开发强效且有效的 SARS-CoV-2 中和纳米抗体。
MAbs. 2021 Jan-Dec;13(1):1958663. doi: 10.1080/19420862.2021.1958663.
7
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.多功能、多价纳米抗体能有效中和 SARS-CoV-2。
Science. 2020 Dec 18;370(6523):1479-1484. doi: 10.1126/science.abe4747. Epub 2020 Nov 5.
8
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies.高效、超耐热且耐突变的纳米抗体对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和作用
EMBO J. 2021 Oct 1;40(19):e107985. doi: 10.15252/embj.2021107985. Epub 2021 Aug 9.
9
Prospects of Neutralizing Nanobodies Against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中和纳米抗体的前景
Front Immunol. 2021 May 28;12:690742. doi: 10.3389/fimmu.2021.690742. eCollection 2021.
10
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.强效中和纳米抗体通过靶向多样化和保守的表位来抵抗 SARS-CoV-2 的集中循环变体。
Nat Commun. 2021 Aug 3;12(1):4676. doi: 10.1038/s41467-021-24963-3.

引用本文的文献

1
Nanobodies: From Discovery to AI-Driven Design.纳米抗体:从发现到人工智能驱动的设计
Biology (Basel). 2025 May 14;14(5):547. doi: 10.3390/biology14050547.
2
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics.对抗病毒入侵者的纳米级战士:关于纳米抗体作为潜在抗病毒疗法的全面综述
MAbs. 2025 Dec;17(1):2486390. doi: 10.1080/19420862.2025.2486390. Epub 2025 Apr 9.
3
A synthetic heavy chain variable domain antibody library (VHL) provides highly functional antibodies with favorable developability.

本文引用的文献

1
NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning.NanoNet:通过深度学习实现快速准确的全流程纳米抗体建模。
Front Immunol. 2022 Aug 12;13:958584. doi: 10.3389/fimmu.2022.958584. eCollection 2022.
2
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.强效中和纳米抗体通过靶向多样化和保守的表位来抵抗 SARS-CoV-2 的集中循环变体。
Nat Commun. 2021 Aug 3;12(1):4676. doi: 10.1038/s41467-021-24963-3.
3
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.
合成重链可变域抗体文库(VHL)可提供具有良好可开发性的高功能抗体。
Protein Sci. 2025 Apr;34(4):e70090. doi: 10.1002/pro.70090.
4
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody.通过使用自标记单域抗体生成位点特异性标记的亲和试剂。
Adv Sci (Weinh). 2025 Apr;12(14):e2417160. doi: 10.1002/advs.202417160. Epub 2025 Feb 18.
5
Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery.重链抗体仅有在转基鸡中稳定的人 VH 用于治疗性抗体的发现。
MAbs. 2024 Jan-Dec;16(1):2435476. doi: 10.1080/19420862.2024.2435476. Epub 2024 Nov 28.
6
Nanobodies: From High-Throughput Identification to Therapeutic Development.纳米抗体:从高通量鉴定到治疗性开发
Mol Cell Proteomics. 2024 Dec;23(12):100865. doi: 10.1016/j.mcpro.2024.100865. Epub 2024 Oct 19.
7
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.VHH 人源化:针对功能结构决定因素的前瞻性病例研究、实验和计算表征。
Protein Sci. 2024 Nov;33(11):e5176. doi: 10.1002/pro.5176.
8
Developability considerations for bispecific and multispecific antibodies.双特异性和多特异性抗体的可开发性考虑因素。
MAbs. 2024 Jan-Dec;16(1):2394229. doi: 10.1080/19420862.2024.2394229. Epub 2024 Aug 27.
9
Single-Domain Antibodies-Novel Tools to Study and Treat Allergies.单域抗体——研究和治疗过敏的新工具。
Int J Mol Sci. 2024 Jul 11;25(14):7602. doi: 10.3390/ijms25147602.
10
Prospects for the computational humanization of antibodies and nanobodies.抗体和纳米抗体计算人源化的前景。
Front Immunol. 2024 May 15;15:1399438. doi: 10.3389/fimmu.2024.1399438. eCollection 2024.
吸入型纳米抗体(PiN-21)可在超低剂量下预防和治疗叙利亚仓鼠感染 SARS-CoV-2。
Sci Adv. 2021 May 26;7(22). doi: 10.1126/sciadv.abh0319. Print 2021 May.
4
Immunogenicity Risk Profile of Nanobodies.纳米抗体的免疫原性风险概况。
Front Immunol. 2021 Mar 9;12:632687. doi: 10.3389/fimmu.2021.632687. eCollection 2021.
5
Immunogenicity and humanization of single-domain antibodies.单域抗体的免疫原性和人源化。
FEBS J. 2022 Jul;289(14):4304-4327. doi: 10.1111/febs.15809. Epub 2021 Mar 25.
6
Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.综合蛋白质组学鉴定出数千种独特的、多表位和高亲和力的纳米抗体。
Cell Syst. 2021 Mar 17;12(3):220-234.e9. doi: 10.1016/j.cels.2021.01.003. Epub 2021 Feb 15.
7
Nanobody: a promising toolkit for molecular imaging and disease therapy.纳米抗体:用于分子成像和疾病治疗的一种有前景的工具集。
EJNMMI Res. 2021 Jan 19;11(1):6. doi: 10.1186/s13550-021-00750-5.
8
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.多功能、多价纳米抗体能有效中和 SARS-CoV-2。
Science. 2020 Dec 18;370(6523):1479-1484. doi: 10.1126/science.abe4747. Epub 2020 Nov 5.
9
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.SARS-CoV-2 和 SARS 冠状病毒受体结合域中高度保守的隐蔽表位。
Science. 2020 May 8;368(6491):630-633. doi: 10.1126/science.abb7269. Epub 2020 Apr 3.
10
Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists.抗药物抗体的分子特征揭示了 TNFα 拮抗剂治疗后免疫反应的机制。
Front Immunol. 2019 Dec 18;10:2921. doi: 10.3389/fimmu.2019.02921. eCollection 2019.